We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.57 | -1.04% | 149.61 | 152.33 | 149.14 | 151.77 | 8,582,138 | 01:00:00 |
From May 2019 to May 2024
AstraZeneca PLC (AZN.LN) said Friday it has sold its rights outside the U.S. for nasal spray Rhinocourt Aqua to Johnson & Johnson (JNJ) affiliate Cilag GmbH International. (In "AstraZeneca Signs $330 Million Deal with Johnson & Johnson Affiliate," at 0630 GMT, the name of the nasal spray was misspelled in the first paragraph.)
(END) Dow Jones Newswires
October 07, 2016 03:36 ET (07:36 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
